Headache News and Research

Latest Headache News and Research

Neurokinin-1 receptor: a potential drug target for the treatment of COVID-19

Neurokinin-1 receptor: a potential drug target for the treatment of COVID-19

New evidence confirms the efficacy of COVID-19 vaccination in cancer patients

New evidence confirms the efficacy of COVID-19 vaccination in cancer patients

I got a ‘mild’ breakthrough case. Here’s what I wish I’d known.

I got a ‘mild’ breakthrough case. Here’s what I wish I’d known.

Medical staff with a history of allergy suffered adverse reactions to BNT162b2 COVID-19 vaccine

Medical staff with a history of allergy suffered adverse reactions to BNT162b2 COVID-19 vaccine

The influence of prior seasonal coronavirus infection on disease severity in COVID-19

The influence of prior seasonal coronavirus infection on disease severity in COVID-19

mAb treatment can rapidly select for SARS-CoV-2 resistance, suggests study

mAb treatment can rapidly select for SARS-CoV-2 resistance, suggests study

Review: Long COVID symptoms rarely persisted beyond 12 weeks in young people

Review: Long COVID symptoms rarely persisted beyond 12 weeks in young people

Researchers examine the persistent effects of COVID-19 on vascular function of young adults

Researchers examine the persistent effects of COVID-19 on vascular function of young adults

Pediatric SARS-CoV-2 infections usually mild, says study

Pediatric SARS-CoV-2 infections usually mild, says study

When covid deaths are dismissed or stigmatized, grief is mixed with shame and anger

When covid deaths are dismissed or stigmatized, grief is mixed with shame and anger

IL-1-Ra autoantibodies observed in high frequency in children with PIMS/MIS-C

IL-1-Ra autoantibodies observed in high frequency in children with PIMS/MIS-C

School children in Switzerland show willingness to mask-wearing

School children in Switzerland show willingness to mask-wearing

German study finds lack of association between SARS-CoV-2 infection and neuroaxonal damage

German study finds lack of association between SARS-CoV-2 infection and neuroaxonal damage

Seizures as a main manifestation of severe pediatric SARS-CoV-2 infection

Seizures as a main manifestation of severe pediatric SARS-CoV-2 infection

V-safe: How everyday people help the CDC track covid vaccine safety with their phones

V-safe: How everyday people help the CDC track covid vaccine safety with their phones

The pandemic almost killed Allie. Her community’s vaccination rate is 45%.

The pandemic almost killed Allie. Her community’s vaccination rate is 45%.

Study sheds light on neurologic symptoms caused by SARS-CoV-2 infection

Study sheds light on neurologic symptoms caused by SARS-CoV-2 infection

Using infodemiology to understand symptoms of SARS-CoV-2 Lambda variant

Using infodemiology to understand symptoms of SARS-CoV-2 Lambda variant

Smell abnormalities more common among long-COVID Patients

Smell abnormalities more common among long-COVID Patients

Your covid game plan: Are stadiums safe?

Your covid game plan: Are stadiums safe?

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.